- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
A20 Negatively Regulates T Cell Receptor Signaling to NF-κB by Cleaving Malt1 Ubiquitin Chains
-
- Michael Düwel
- Helmholtz Zentrum München, German Research Center for Environmental Health, Institute of Toxicology , Neuherberg,
-
- Verena Welteke
- Helmholtz Zentrum München, German Research Center for Environmental Health, Institute of Toxicology , Neuherberg,
-
- Andrea Oeckinghaus
- Helmholtz Zentrum München, German Research Center for Environmental Health, Institute of Toxicology , Neuherberg,
-
- Mathijs Baens
- Human Genome Laboratory, Molecular Genetics, Center for Human Genetics, University of Leuven , Leuven,
-
- Bernhard Kloo
- Helmholtz Zentrum München, German Research Center for Environmental Health, Institute of Toxicology , Neuherberg,
-
- Uta Ferch
- Medical Department, Klinikum rechts der Isar, Technical University of Munich , Munich,
-
- Bryant G Darnay
- Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center , Houston, TX
-
- Jürgen Ruland
- Medical Department, Klinikum rechts der Isar, Technical University of Munich , Munich,
-
- Peter Marynen
- Human Genome Laboratory, Molecular Genetics, Center for Human Genetics, University of Leuven , Leuven,
-
- Daniel Krappmann
- Helmholtz Zentrum München, German Research Center for Environmental Health, Institute of Toxicology , Neuherberg,
Search this article
Description
<jats:title>Abstract</jats:title> <jats:p>The Carma1-Bcl10-Malt1 signaling module bridges TCR signaling to the canonical IκB kinase (IKK)/NF-κB pathway. Covalent attachment of regulatory ubiquitin chains to Malt1 paracaspase directs TCR signaling to IKK activation. Further, the ubiquitin-editing enzyme A20 was recently suggested to suppress T cell activation, but molecular targets for A20 remain elusive. In this paper, we show that A20 regulates the strength and duration of the IKK/NF-κB response upon TCR/CD28 costimulation. By catalyzing the removal of K63-linked ubiquitin chains from Malt1, A20 prevents sustained interaction between ubiquitinated Malt1 and the IKK complex and thus serves as a negative regulator of inducible IKK activity. Upon T cell stimulation, A20 is rapidly removed and paracaspase activity of Malt1 has been suggested to cleave A20. Using antagonistic peptides or reconstitution of Malt1−/− T cells, we show that Malt1 paracaspase activity is required for A20 cleavage and optimal IL-2 production, but dispensable for initial IKK/NF-κB signaling in CD4+ T cells. However, proteasomal inhibition impairs A20 degradation and impedes TCR/CD28-induced IKK activation. Taken together, A20 functions as a Malt1 deubiquitinating enzyme and proteasomal degradation and de novo synthesis of A20 contributes to balance TCR/CD28-induced IKK/NF-κB signaling.</jats:p>
Journal
-
- The Journal of Immunology
-
The Journal of Immunology 182 (12), 7718-7728, 2009-06
Oxford University Press (OUP)
- Tweet
Details 詳細情報について
-
- CRID
- 1360011144670214784
-
- ISSN
- 15506606
- 00221767
-
- Data Source
-
- Crossref